PERSONALIS INC (PSNL) Stock Fundamental Analysis

NASDAQ:PSNL • US71535D1063

8.21 USD
-0.18 (-2.15%)
At close: Feb 13, 2026
8.55 USD
+0.34 (+4.14%)
After Hours: 2/13/2026, 8:00:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall PSNL gets a fundamental rating of 2 out of 10. We evaluated PSNL against 58 industry peers in the Life Sciences Tools & Services industry. While PSNL seems to be doing ok healthwise, there are quite some concerns on its profitability. PSNL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year PSNL has reported negative net income.
  • PSNL had a negative operating cash flow in the past year.
  • In the past 5 years PSNL always reported negative net income.
  • In the past 5 years PSNL always reported negative operating cash flow.
PSNL Yearly Net Income VS EBIT VS OCF VS FCFPSNL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -30.42%, PSNL is doing worse than 75.86% of the companies in the same industry.
  • With a Return On Equity value of -43.10%, PSNL is not doing good in the industry: 68.97% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -30.42%
ROE -43.1%
ROIC N/A
ROA(3y)-38.97%
ROA(5y)-30.04%
ROE(3y)-58.56%
ROE(5y)-43.57%
ROIC(3y)N/A
ROIC(5y)N/A
PSNL Yearly ROA, ROE, ROICPSNL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

  • PSNL has a worse Gross Margin (26.67%) than 79.31% of its industry peers.
  • In the last couple of years the Gross Margin of PSNL has remained more or less at the same level.
  • PSNL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.05%
GM growth 5Y-1.31%
PSNL Yearly Profit, Operating, Gross MarginsPSNL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200 -250

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • PSNL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, PSNL has more shares outstanding
  • The number of shares outstanding for PSNL has been increased compared to 5 years ago.
  • PSNL has a better debt/assets ratio than last year.
PSNL Yearly Shares OutstandingPSNL Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
PSNL Yearly Total Debt VS Total AssetsPSNL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • PSNL has an Altman-Z score of 2.62. This is not the best score and indicates that PSNL is in the grey zone with still only limited risk for bankruptcy at the moment.
  • PSNL has a better Altman-Z score (2.62) than 67.24% of its industry peers.
  • PSNL has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of PSNL (0.00) is better than 68.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.62
ROIC/WACCN/A
WACC10.81%
PSNL Yearly LT Debt VS Equity VS FCFPSNL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 4.82 indicates that PSNL has no problem at all paying its short term obligations.
  • PSNL's Current ratio of 4.82 is fine compared to the rest of the industry. PSNL outperforms 75.86% of its industry peers.
  • PSNL has a Quick Ratio of 4.69. This indicates that PSNL is financially healthy and has no problem in meeting its short term obligations.
  • PSNL's Quick ratio of 4.69 is amongst the best of the industry. PSNL outperforms 84.48% of its industry peers.
Industry RankSector Rank
Current Ratio 4.82
Quick Ratio 4.69
PSNL Yearly Current Assets VS Current LiabilitesPSNL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 47.62% over the past year.
  • Looking at the last year, PSNL shows a very negative growth in Revenue. The Revenue has decreased by -21.02% in the last year.
  • PSNL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.35% yearly.
EPS 1Y (TTM)47.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.5%
Revenue 1Y (TTM)-21.02%
Revenue growth 3Y-0.34%
Revenue growth 5Y5.35%
Sales Q2Q%-43.62%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.53% on average over the next years. This is quite good.
  • PSNL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.22% yearly.
EPS Next Y29.59%
EPS Next 2Y12.8%
EPS Next 3Y12.1%
EPS Next 5Y14.53%
Revenue Next Year-16.29%
Revenue Next 2Y-0.02%
Revenue Next 3Y9.02%
Revenue Next 5Y13.22%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PSNL Yearly Revenue VS EstimatesPSNL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
PSNL Yearly EPS VS EstimatesPSNL Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PSNL. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PSNL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PSNL Price Earnings VS Forward Price EarningsPSNL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PSNL Per share dataPSNL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

  • PSNL's earnings are expected to grow with 12.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.8%
EPS Next 3Y12.1%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for PSNL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PERSONALIS INC

NASDAQ:PSNL (2/13/2026, 8:00:00 PM)

After market: 8.55 +0.34 (+4.14%)

8.21

-0.18 (-2.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-04
Earnings (Next)02-19
Inst Owners54.55%
Inst Owner Change1.1%
Ins Owners1.14%
Ins Owner Change-0.21%
Market Cap729.05M
Revenue(TTM)69.10M
Net Income(TTM)-73.88M
Analysts83.08
Price Target11.22 (36.66%)
Short Float %15.02%
Short Ratio6.18
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.52%
Min EPS beat(2)7.49%
Max EPS beat(2)15.55%
EPS beat(4)4
Avg EPS beat(4)18.13%
Min EPS beat(4)7.49%
Max EPS beat(4)28.59%
EPS beat(8)6
Avg EPS beat(8)7.71%
EPS beat(12)8
Avg EPS beat(12)6.28%
EPS beat(16)11
Avg EPS beat(16)6.11%
Revenue beat(2)1
Avg Revenue beat(2)-4.68%
Min Revenue beat(2)-16.15%
Max Revenue beat(2)6.79%
Revenue beat(4)3
Avg Revenue beat(4)2.82%
Min Revenue beat(4)-16.15%
Max Revenue beat(4)15.99%
Revenue beat(8)6
Avg Revenue beat(8)5.8%
Revenue beat(12)9
Avg Revenue beat(12)5.37%
Revenue beat(16)12
Avg Revenue beat(16)5.55%
PT rev (1m)0%
PT rev (3m)47.9%
EPS NQ rev (1m)-0.49%
EPS NQ rev (3m)-5.56%
EPS NY rev (1m)-0.15%
EPS NY rev (3m)1.94%
Revenue NQ rev (1m)0.38%
Revenue NQ rev (3m)-19.38%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)-4.37%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.55
P/FCF N/A
P/OCF N/A
P/B 4.25
P/tB 4.25
EV/EBITDA N/A
EPS(TTM)-0.88
EYN/A
EPS(NY)-1
Fwd EYN/A
FCF(TTM)-0.75
FCFYN/A
OCF(TTM)-0.68
OCFYN/A
SpS0.78
BVpS1.93
TBVpS1.93
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -30.42%
ROE -43.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.67%
FCFM N/A
ROA(3y)-38.97%
ROA(5y)-30.04%
ROE(3y)-58.56%
ROE(5y)-43.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.05%
GM growth 5Y-1.31%
F-Score3
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 56.02%
Cap/Sales 8.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.82
Quick Ratio 4.69
Altman-Z 2.62
F-Score3
WACC10.81%
ROIC/WACCN/A
Cap/Depr(3y)234.39%
Cap/Depr(5y)188.79%
Cap/Sales(3y)31.15%
Cap/Sales(5y)22.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.5%
EPS Next Y29.59%
EPS Next 2Y12.8%
EPS Next 3Y12.1%
EPS Next 5Y14.53%
Revenue 1Y (TTM)-21.02%
Revenue growth 3Y-0.34%
Revenue growth 5Y5.35%
Sales Q2Q%-43.62%
Revenue Next Year-16.29%
Revenue Next 2Y-0.02%
Revenue Next 3Y9.02%
Revenue Next 5Y13.22%
EBIT growth 1Y-15.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-16.79%
EBIT Next 3Y-1.8%
EBIT Next 5Y15.71%
FCF growth 1Y13.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.5%
OCF growth 3YN/A
OCF growth 5YN/A

PERSONALIS INC / PSNL FAQ

Can you provide the ChartMill fundamental rating for PERSONALIS INC?

ChartMill assigns a fundamental rating of 2 / 10 to PSNL.


Can you provide the valuation status for PERSONALIS INC?

ChartMill assigns a valuation rating of 0 / 10 to PERSONALIS INC (PSNL). This can be considered as Overvalued.


What is the profitability of PSNL stock?

PERSONALIS INC (PSNL) has a profitability rating of 0 / 10.


What is the financial health of PERSONALIS INC (PSNL) stock?

The financial health rating of PERSONALIS INC (PSNL) is 5 / 10.